News
SIGA
8.64
-0.23%
-0.02
Weekly Report: what happened at SIGA last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at SIGA last week (0408-0412)?
Weekly Report · 04/15 12:00
Best Momentum Stocks to Buy for April 12th
NASDAQ · 04/12 14:00
New Strong Buy Stocks for April 12th
NASDAQ · 04/12 11:29
Best Value Stocks to Buy for April 12th
NASDAQ · 04/12 10:33
WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC alone, more than 4500 cases of #mpox and almost 300 deaths have been reported this year. That is triple the number reported at this time last year. The recent surge in cases and deaths among children is of particular concern, along with the re-emergence of Clade One in central Africa...."
Benzinga · 04/11 14:09
Best Momentum Stocks to Buy for April 10th
NASDAQ · 04/10 14:00
New Strong Buy Stocks for April 10th
NASDAQ · 04/10 10:44
Weekly Report: what happened at SIGA last week (0401-0405)?
Weekly Report · 04/08 12:06
Wall Street Breakfast: The Week Ahead
Seeking Alpha · 04/07 08:59
Catalyst Watch: CPI reveal, big bank earnings & AI talk from Intel and Marvell
Consumer price index report for March is expected to be higher than expected. A total solar eclipse will turn day into night across parts of North America on Monday. The Federal Reserve will release the minutes from the March 19-20 meeting. Intel and Marvell will show off their AI technology at a conference in Phoenix, Arizona.
Seeking Alpha · 04/05 19:00
Notable Tuesday Option Activity: RBLX, SIGA, ISRG
NASDAQ · 04/02 19:26
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ:SNAX) fell sharply following a fourth-quarter revenue miss. The company posted adjusted loss of $1.90 per share. VivoPower International PLC shares surged 315% to $6.10 after the company announced a merger.
Benzinga · 04/02 17:23
ChampionX, Montrose Environmental Group And Other Big Stocks Moving Higher On Tuesday
U.S. Stocks were lower on Tuesday, with the Dow Jones falling around 400 points. Shares of ChampionX Corporation rose sharply after Schlumberger announced it will acquire the company. VirTra, Inc. Shares jumped 32.8% to $12.67 after reporting better-than-expected fourth-quarter results.
Benzinga · 04/02 14:30
Best Momentum Stocks to Buy for April 2nd
NASDAQ · 04/02 14:00
New Strong Buy Stocks for April 2nd
NASDAQ · 04/02 11:05
Siga Technologie: Current report
Press release · 04/01 23:54
SIGA Technologies amends international promotion agreement with Meridian
Healthcare SIGA Technologies amends international promotion agreement with Meridian Medical Technologies. SIGA will drive international promotion activities for oral TPOXX. The amendment extends the term of the promotion agreement by two years with respect to specific territories including the European Union. SIGa Technologies, Inc. (SIGA) Stock
Seeking Alpha · 04/01 20:10
SIGA Technologies Enters Amendment To Its International Promotion Agreement With Meridian Medical
Effective June 1, SIGA will drive international promotion activities for oral TPOXX. The agreement with Meridian extends the term of the promotion agreement by two years. SIGA has primary responsibility for promoting oral T POXX in the European Union. Meridian's contract with the European Commission will remain in effect.
Benzinga · 04/01 20:07
SIGA TECHNOLOGIES INC - EFFECTIVE JUNE 1, SIGA WILL DRIVE INTERNATIONAL PROMOTION ACTIVITIES FOR ORAL TPOXX
Reuters · 04/01 20:05
More
Webull provides a variety of real-time SIGA stock news. You can receive the latest news about Siga Technologie through multiple platforms. This information may help you make smarter investment decisions.
About SIGA
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.